TrialScientific reports2024
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
R Audran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialScientific reports2024
R Audran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.